查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830956

近距離放射治療設備市場

Brachytherapy Devices Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

近距離放射治療設備市場預計將從 2024 年的 3.4357 億美元增加到 2031 年的 5.342 億美元，2025 年至 2031 年的複合年成長率預計為 6.7%。

分析師觀點

近距離放射治療，又稱為內放射治療 (IRT)，是指將放射性裝置（例如粒子、帶狀物、導線、針頭、膠囊、球囊或導管）放置在腫瘤附近，以釋放集中劑量的放射線。這種方法可以有效地破壞和縮小腫瘤。與其他放射療法不同，近距離放射治療允許更高的放射劑量，同時最大限度地減少對鄰近器官的損害。癌症發生率的上升極大地推動了近距離放射治療設備市場的成長。此外，技術的進步和內放射治療在癌症治療中的應用日益廣泛也促進了市場的擴張。然而，近距離放射治療的相關風險以及熟練技術人員的短缺對市場成長構成了挑戰。

市場概況

乳癌、攝護腺癌和子宮頸癌等癌症發生率的不斷上升是推動近距離放射治療設備市場發展的關鍵因素。根據世界衛生組織 (WHO) 2024 年 2 月發布的資料，2022 年全球報告約有 2,000 萬例新發癌症病例和 970 萬例癌症死亡病例。其中，乳癌最常見，女性確診病例達 230 萬例。攝護腺癌和大腸癌分別是男性第二大和第三大常見癌症。近距離放射治療設備通常用於有效治療婦科癌症、攝護腺癌、乳癌和其他各種癌症。這些設備包括含有放射性物質的導線、粒子或棒，被植入腫瘤附近，以便在特定距離內發射輻射。

此外，與其他放射療法相比，近距離放射治療通常速度更快，副作用更少。愛思唯爾於2023年6月發表的一項研究，利用大型多機構資料庫，比較了近距離放射治療與外照射放射治療 (EBRT) 的結果，結果顯示，與EBRT相比，近距離放射治療具有更高的生存率和更低的遠處轉移發生率。這項發現至關重要，有望推動近距離放射治療成為中高風險前列腺癌患者經濟有效的治療方法。

隨著全球癌症盛行率持續上升，近距離放射治療作為一種廣泛可用的治療選擇的需求極大地促進了近距離放射治療設備市場的成長。

戰略洞察

報告細分和範圍

「近距離放射治療設備市場分析」考慮了以下幾個部分：產品類型、類型、應用和最終用戶。

市場按產品類型細分為粒子、近距離放射治療後裝器和施放器以及電子近距離放射治療。按類型細分，市場分為高劑量率近距離放射治療植入物和低劑量率近距離放射治療植入物。市場也按應用細分為乳癌、子宮頸癌、攝護腺癌、肺癌等。

根據最終用戶，市場分為醫院和專科診所、門診手術中心和其他。

全球近距離放射治療設備市場報告的範圍包括北美（美國、加拿大和墨西哥）、歐洲（德國、法國、義大利、英國、西班牙和歐洲其他地區）、亞太地區（中國、日本、印度、澳洲、韓國和亞太其他地區）、中東和非洲（南非、沙烏地阿拉伯、阿拉伯聯合大公國和中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲（巴西、阿根廷和南美洲和其他地區）。

按產品類型分類的見解

根據產品類型，近距離放射治療設備市場分為粒子、近距離放射治療後裝器和施用器以及電子近距離放射治療。近距離放射治療後裝置和施用器細分市場在2022年佔據最大市場佔有率，預計在2022年至2030年期間的複合年成長率最高。

按類型分類的見解

市場按類型分為高劑量近距離放射治療植入物和低劑量率近距離放射治療植入物。低劑量率近距離放射治療植入物在2022年佔據了近距離放射治療設備市場的較大佔有率，預計在2022年至2030年期間將以更快的複合年成長率成長。

按應用程式洞察

近距離放射治療設備市場按應用細分為乳癌、子宮頸癌、攝護腺癌、肺癌等。前列腺癌領域在2022年佔據了最大的市場佔有率，預計在2022年至2030年期間將實現最高的複合年成長率。

最終使用者的見解

按最終用戶分類，市場分為醫院和專科診所、門診手術中心和其他類型。 2022年，醫院佔據了最大的市場佔有率，這歸因於與其他手術中心相比，醫院擁有更優越的設施和更熟練的醫生，可以進行微創手術。

區域分析

從地理來看，市場細分為北美、亞太地區、歐洲、中東和非洲以及南美和中美。 2022年，北美在近距離放射治療設備市場收入方面領先，主要由美國推動。這種主導地位源自於多種因素，包括該地區女性乳癌和男性前列腺癌發生率的上升。根據泛美衛生組織 (PAHO) 的數據，2020年美洲約有400萬人被診斷出罹患癌症，預計到2040年將增加約60%。

此外，BD、Isoray Inc. 和 Elekta 等主要市場參與者的加入，以及先進近距離放射治療設備的供應，為市場成長帶來了巨大的機會。例如，2021 年 7 月，GenesisCare 從 Elekta 收購了 27 台 Flexitron 近距離放射治療後裝系統及服務協議，從而擴展了其近距離放射治療服務，使其能夠掌握最新技術，並為其在美國各地中心的患者提供高品質的護理。

近距離放射治療設備市場報告範圍：產業發展與未來機會：近距離放射治療設備市場預測可以幫助利害關係人規劃其成長策略。根據公司新聞稿，全球市場領導企業的幾項策略發展重點如下：

2023年10月，醫科達（Elekta）宣布透過資產收購的方式，從iCAD公司收購Xoft業務。此次收購Xoft Axxent電子近距離放射治療（eBx）系統以及員工轉移旨在增強公司提供的癌症治療方案和電子近距離放射治療技術。 2023年7月，CIVCO Radiotherapy公司在2022年10月23日至26日於德克薩斯州聖安東尼奧舉行的美國放射腫瘤學會（ASTRO）年會上宣布與專門生產患者定位和固定設備的公司Qfix建立合作夥伴關係。 2022年7月，BEBIG Medical公司收購了德國公司Wolf-Medizintechnik GmbH（WOmed），該公司在全球提供先進的X光治療和新開發的術中放射治療產品。此次收購旨在增強BEBIG Medical在癌症放射治療領域的產品組合。

2020年12月，瓦里安醫療系統公司推出了四套新型近距離放射治療施放器，用於針對陰道、子宮頸、子宮、子宮內膜和直腸的高動態範圍（HDR）近距離放射治療。這些新型施放器旨在解決尺寸、易用性和MRI成像支援方面的問題，使其更加方便用戶使用，患者使用更加舒適，使臨床醫生能夠在門診治療更多患者。近距離放射治療設備市場報告中介紹的主要公司包括醫科達（Elekta）、瓦里安醫療系統公司（Varian Medical Systems, Inc.）、BEBIG Medical、Theragenics Corporation、IsoAid、西門子醫療系統公司（Siemens Healthineers AG）、BXTA、BD、Eckert and Ziegler股份公司以及Perspective Therapyeutics。這些領導企業正致力於擴大和多元化其市場影響力和客戶群，以抓住市場商機。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解
  • 市場吸引力分析

第3章：研究方法

第4章：近距離放射治療設備市場格局

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：近距離放射治療設備市場－關鍵市場動態

  • 關鍵市場促進因素
  • 主要市場限制因素
  • 關鍵市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響分析

第6章：近距離放射治療設備市場－全球市場分析

  • 近距離放射治療設備 - 全球市場概覽
  • 近距離放射治療設備－全球市場及2031年預測

第7章：近距離放射治療設備市場-收入分析-依產品類型，2021-2031

  • 概述
  • 種子
  • 近距離放射治療後裝器和施放器
  • 電子近距離放射治療

第 8 章：近距離放射治療設備市場 - 收入分析 - 按類型，2021-2031 年

  • 概述
  • 高劑量率近距離放射治療植入物
  • 低劑量率近距離放射治療植入物

第9章：近距離放射治療設備市場-收入分析-按應用，2021-2031

  • 概述
  • 乳癌
  • 子宮頸癌
  • 攝護腺癌
  • 肺癌
  • 其他

第 10 章：近距離放射治療設備市場 - 收入分析 - 按最終用戶，2021-2031 年

  • 概述
  • 醫院和專科診所
  • 門診手術中心
  • 其他

第 11 章：近距離放射治療設備市場 - 收入分析，2021-2031 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 13 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 14 章：近距離放射治療設備市場 - 主要公司簡介

  • Elekta
  • Varian Medical Systems, Inc
  • BEBIG Medical
  • Theragenics Corporation
  • IsoAid
  • Siemens Healthineers AG
  • BXTA
  • BD
  • Eckert and Ziegler
  • Perspective Therapeutics

第 15 章：附錄

簡介目錄
Product Code: TIPHE100001169

The brachytherapy devices market is projected to increase from US$ 343.57 million in 2024 to US$ 534.20 million by 2031, with an estimated CAGR of 6.7% from 2025 to 2031.

Analyst Perspective

Brachytherapy, or internal radiation therapy (IRT), involves placing radioactive devices such as seeds, ribbons, wires, needles, capsules, balloons, or tubes close to tumors to deliver concentrated doses of radiation. This method is effective in destroying and reducing tumors. Unlike other radiation therapies, brachytherapy allows for higher radiation doses while minimizing harm to adjacent organs. The rising incidence of cancers significantly drives the growth of the brachytherapy devices market. Furthermore, advancements in technology and the increasing use of IRTs for cancer treatment are also contributing to market expansion. However, the risks associated with brachytherapy and a shortage of skilled technicians pose challenges to market growth.

Market Overview

The growing incidence of cancers, such as breast, prostate, and cervical cancer, is a key factor driving the brachytherapy devices market. According to data released by the World Health Organization (WHO) in February 2024, approximately 20 million new cancer cases and 9.7 million cancer-related deaths were reported worldwide in 2022. Among these, breast cancer was the most prevalent, with 2.3 million cases diagnosed in women. Prostate and colorectal cancers rank as the second and third most common cancers in men, respectively. Brachytherapy devices are commonly utilized to effectively treat gynecologic, prostate, breast, and various other cancers. These devices, which include wires, seeds, or rods containing radioactive materials, are implanted near tumors to deliver radiation over a specific distance.

Additionally, brachytherapy is generally quicker and has fewer side effects compared to other radiation therapies. A study published by Elsevier in June 2023 compared the outcomes of brachytherapy with external beam radiation therapy (EBRT) using a large multi-institutional database, revealing that brachytherapy is associated with better survival rates and a lower incidence of distant cancer metastases compared to EBRT. This finding is crucial and may promote the adoption of brachytherapy as a cost-effective and efficient treatment for patients with intermediate- to high-risk prostate cancer.

As the global cancer prevalence continues to rise, the demand for brachytherapy as a widely accessible treatment option significantly contributes to the growth of the brachytherapy devices market.

Strategic Insights

Report Segmentation and Scope

The "brachytherapy devices market analysis" has been conducted considering the following segments: product type, type, application, and end user.

The market is segmented by product type into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. By type, the market is divided into high-dose rate brachytherapy implants and low-dose rate brachytherapy implants. The market is also segmented by application into breast cancer, cervical cancer, prostate cancer, lung cancer, and others.

By end user, the market is categorized into hospitals and specialty clinics, ambulatory surgical centers, and others.

The scope of the global brachytherapy devices market report includes North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Insights by Product Type

Based on product type, the brachytherapy devices market is divided into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. The brachytherapy afterloaders and applicators segment held the largest market share in 2022 and is expected to exhibit the highest CAGR from 2022 to 2030.

Insights by Type

The market is categorized by type into high-dose brachytherapy implants and low-dose rate brachytherapy implants. The low-dose rate brachytherapy implant segment accounted for a larger share of the brachytherapy devices market in 2022 and is projected to grow at a faster CAGR from 2022 to 2030.

Insights by Application

The brachytherapy devices market is segmented by application into breast cancer, cervical cancer, prostate cancer, lung cancer, and others. The prostate cancer segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022 to 2030.

Insights by End User

By end user, the market is divided into hospitals and specialty clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022, attributed to the availability of superior facilities and skilled physicians in hospitals compared to other surgical centers for performing minimally invasive procedures.

Regional Analysis

Geographically, the market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America led the brachytherapy devices market in terms of revenue in 2022, primarily driven by the US. This dominance is due to several factors, including the rising incidence of breast cancer among women and prostate cancer among men in the region. According to the Pan America Health Organization (PAHO), approximately 4 million people in the Americas were diagnosed with cancer in 2020, with projections indicating a ~60% increase by 2040.

Moreover, the presence of key market players such as BD, Isoray Inc., and Elekta, along with the availability of advanced brachytherapy devices, presents significant opportunities for market growth. For example, in July 2021, GenesisCare expanded its brachytherapy services by acquiring 27 Flexitron brachytherapy afterloader systems and service agreements from Elekta, enabling them to stay updated with the latest technology and provide high-quality care to patients across their centers in the US.

Brachytherapy Devices Market Report ScopeIndustry Developments and Future Opportunities:The brachytherapy devices market forecast can assist stakeholders in planning their growth strategies. According to company press releases, several strategic developments by leading players in the global market are highlighted below:

In October 2023, Elekta announced the acquisition of the Xoft business from iCAD, Inc. through an asset acquisition. This acquisition of the Xoft Axxent Electronic Brachytherapy (eBx) System, along with the transfer of employees, aims to enhance the range of cancer treatment options and electronic brachytherapy technology offered by the company.In July 2023, CIVCO Radiotherapy announced a partnership with Qfix, a company specializing in devices for patient positioning and immobilization, during the American Society for Radiation Oncology (ASTRO) Annual Meeting held from October 23-26, 2022, in San Antonio, Texas.In July 2022, BEBIG Medical acquired Wolf-Medizintechnik GmbH (WOmed), a German company that provides advanced X-ray therapy and newly developed intraoperative radiation therapy products globally. This acquisition aimed to enhance BEBIG Medical's product offerings in radiation therapy for cancer treatment.

In December 2020, Varian Medical Systems, Inc. launched four new brachytherapy applicator sets for HDR brachytherapy targeting the vagina, cervix, uterus, endometrium, and rectum. These new applicators are designed to address size, usability, and MRI imaging support issues, making them more user-friendly and comfortable for patients, thus allowing clinicians to treat more patients on an outpatient basis.Key companies profiled in the brachytherapy devices market report include Elekta, Varian Medical Systems, Inc., BEBIG Medical, Theragenics Corporation, IsoAid, Siemens Healthineers AG, BXTA, BD, Eckert and Ziegler, and Perspective Therapeutics. These leading players are focused on expanding and diversifying their market presence and clientele, seizing business opportunities in the market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Brachytherapy Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Brachytherapy Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Brachytherapy Devices Market - Global Market Analysis

  • 6.1 Brachytherapy Devices - Global Market Overview
  • 6.2 Brachytherapy Devices - Global Market and Forecast to 2031

7. Brachytherapy Devices Market - Revenue Analysis (USD Million) - By Product Type, 2021-2031

  • 7.1 Overview
  • 7.2 Seeds
  • 7.3 Brachytherapy Afterloaders and Applicators
  • 7.4 Electronic Brachytherapy

8. Brachytherapy Devices Market - Revenue Analysis (USD Million) - By Type, 2021-2031

  • 8.1 Overview
  • 8.2 High Dose Rate Brachytherapy Implants
  • 8.3 Low Dose Rate Brachytherapy Implants

9. Brachytherapy Devices Market - Revenue Analysis (USD Million) - By Application, 2021-2031

  • 9.1 Overview
  • 9.2 Breast Cancer
  • 9.3 Cervical Cancer
  • 9.4 Prostate Cancer
  • 9.5 Lung Cancer
  • 9.6 Others

10. Brachytherapy Devices Market - Revenue Analysis (USD Million) - By End User, 2021-2031

  • 10.1 Overview
  • 10.2 Hospital and Specialty Clinics
  • 10.3 Ambulatory Surgical Centers
  • 10.4 Others

11. Brachytherapy Devices Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Brachytherapy Devices Market Overview
    • 11.1.2 North America Brachytherapy Devices Market Revenue and Forecasts to 2031
    • 11.1.3 North America Brachytherapy Devices Market Revenue and Forecasts and Analysis - By Product Type
    • 11.1.4 North America Brachytherapy Devices Market Revenue and Forecasts and Analysis - By Type
    • 11.1.5 North America Brachytherapy Devices Market Revenue and Forecasts and Analysis - By Application
    • 11.1.6 North America Brachytherapy Devices Market Revenue and Forecasts and Analysis - By End User
    • 11.1.7 North America Brachytherapy Devices Market Revenue and Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Brachytherapy Devices Market
        • 11.1.7.1.1 United States Brachytherapy Devices Market, by Product Type
        • 11.1.7.1.2 United States Brachytherapy Devices Market, by Type
        • 11.1.7.1.3 United States Brachytherapy Devices Market, by Application
        • 11.1.7.1.4 United States Brachytherapy Devices Market, by End User
      • 11.1.7.2 Canada Brachytherapy Devices Market
        • 11.1.7.2.1 Canada Brachytherapy Devices Market, by Product Type
        • 11.1.7.2.2 Canada Brachytherapy Devices Market, by Type
        • 11.1.7.2.3 Canada Brachytherapy Devices Market, by Application
        • 11.1.7.2.4 Canada Brachytherapy Devices Market, by End User
      • 11.1.7.3 Mexico Brachytherapy Devices Market
        • 11.1.7.3.1 Mexico Brachytherapy Devices Market, by Product Type
        • 11.1.7.3.2 Mexico Brachytherapy Devices Market, by Type
        • 11.1.7.3.3 Mexico Brachytherapy Devices Market, by Application
        • 11.1.7.3.4 Mexico Brachytherapy Devices Market, by End User
  • 11.2 Europe
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 Italy
    • 11.2.4 Spain
    • 11.2.5 United Kingdom
    • 11.2.6 Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1 Australia
    • 11.3.2 China
    • 11.3.3 India
    • 11.3.4 Japan
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia-Pacific
  • 11.4 Middle East and Africa
    • 11.4.1 South Africa
    • 11.4.2 Saudi Arabia
    • 11.4.3 U.A.E
    • 11.4.4 Rest of Middle East and Africa
  • 11.5 South and Central America
    • 11.5.1 Brazil
    • 11.5.2 Argentina
    • 11.5.3 Rest of South and Central America

12. Industry Landscape

  • 12.1 Mergers and Acquisitions
  • 12.2 Agreements, Collaborations, Joint Ventures
  • 12.3 New Product Launches
  • 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Brachytherapy Devices Market - Key Company Profiles

  • 14.1 Elekta
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Varian Medical Systems, Inc
  • 14.3 BEBIG Medical
  • 14.4 Theragenics Corporation
  • 14.5 IsoAid
  • 14.6 Siemens Healthineers AG
  • 14.7 BXTA
  • 14.8 BD
  • 14.9 Eckert and Ziegler
  • 14.10 Perspective Therapeutics

15. Appendix

  • 15.1 Glossary
  • 15.2 About The Insight Partners
  • 15.3 Market Intelligence Cloud